Washington, DC —(ENEWSPF)—June 7, 2018 Contact: Karen Conner The current system of financing clinical trials for prescription drugs and medical devices, which relies primarily on corporate funding, makes little useful information available to researchers and practitioners. Limiting the availability of data on how various demographic groups performed in trials is denying[Read More…]
Health and Fitness
Shearer’s Foods, LLC Issues an Allergy Alert for Meijer Brand Dill Pickle Flavored Potato Chips
Silver Spring, Maryland—(ENEWSPF)—June 7, 2018 By: Rosemary Piser The Food and Drug Administration (FDA) announced that Shearer’s Foods, LLC of Massillon, OH is recalling certain Meijer brand Dill Pickle Flavored Potato Chips. The recalled products may contain undeclared milk. People who are allergic to milk run the risk of serious[Read More…]
FDA Warns Companies to Stop Selling Dangerous and Illegal Pure and Highly Concentrated Caffeine Products
Silver Spring, Maryland—(ENEWSPF)—June 5, 2018 Contact: Theresa Eisenman The U.S. Food and Drug Administration has issued warning letters to the parties responsible for liquidcaffeine.com and Dual Health Body and Mind for illegally selling certain highly concentrated caffeine products. The FDA considers these products to be a threat to public health.[Read More…]
FDA Takes Action Against 53 Websites Marketing Unapproved Opioids
Actions are part of a comprehensive effort to target illegal online sales Silver Spring, Maryland—(ENEWSPF)—June 5, 2018 Contact: Tara Rabin The U.S. Food and Drug Administration today announced that it has warned nine online networks, operating a total of 53 websites, that they must stop illegally marketing potentially dangerous, unapproved[Read More…]
New Approach to Immunotherapy Leads to Complete Response in Breast Cancer Patient Unresponsive to Other Treatments
Bethesda, Maryland—(ENEWSPF)—June 4, 2018 By: National Institutes of Health Communications A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a[Read More…]
World Health Organization Finds Increased Cancer Risk for Chemical Found in Plastics
PENNSYLVANIA—(ENEWSPF)—June 4, 2018 Contacts: Alex Truelove, Kara Cook-Schultz After years of scientific research and evidence collection, the cancer agency at the World Health Organization (WHO) has now classified styrene as a “probable carcinogen.” Styrene is a chemical building block of polystyrene, the plastic material used to make styrofoam and many[Read More…]
Self-tuning Brain Implant Could Help Treat Patients with Parkinson’s Disease (Video)
NIH BRAIN Initiative-funded research a key first step to improving deep brain stimulation. Bethesda, Maryland—(ENEWSPF)—May 29, 2018 Contact: Carl P. Wonders, Ph.D. Deep brain stimulation has been used to treat Parkinson’s disease symptoms for 25 years, but limitations have led researchers to look for ways to improve the technique. This[Read More…]
Survey: Oncologists Believe Medical Cannabis To Be Equally Or More Effective Than Conventional Treatments
Boston, MA—(ENEWSPF)—May 25, 2018 Contact: Paul Armentano, NORML Deputy Director The majority of oncologists believe that the use of medical cannabis is either as effective or more effective than conventional treatments for managing symptoms of cancer, according to survey data published in The Journal of Clinical Oncology. A team of[Read More…]
Study: CBD Extracts Safe And Effective In Treating Rare Form Of Pediatric Epilepsy
New York, NY—(ENEWSPF)—May 25, 2018 Contact: Paul Armentano, NORML Deputy Director The daily administration of a proprietary CBD extract (Epidiolex) is safe and effective in the treatment of Lennox-Gastaut syndrome, a severe form of pediatric epilepsy, according to clinical data published in The New England Journal of Medicine. An international[Read More…]
Study: THC/CBD Administration Not Associated With Driving Impairment
Oslo, Norway—(ENEWSPF)—May 25, 2018 Contact: Paul Armentano, NORML Deputy Director The administration of an oral spray containing equal ratios of THC and CBD is not associated with either driving impairment or an increased risk of motor vehicle accident, according to a literature review published in the journal Brain and Behavior.[Read More…]
